Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
Authors:
- Ju Hyeon KimJKJu Hyeon Kim
- Jung-Joon ChaJCJung-Joon Cha
- Subin LimSLSubin Lim
- Jungseok AnJAJungseok An
- Mi-Na KimMKMi-Na Kim
- Soon Jun HongSHSoon Jun Hong
- Hyung Joon JooHyung Joon Joo
- Jae Hyoung ParkJPJae Hyoung Park
- Cheol Woong YuCYCheol Woong Yu
- Do-Sun LimDLDo-Sun Lim
- Kyeongmin ByeonKBKyeongmin Byeon
- Sang-Wook KimSKSang-Wook Kim
Open Access
- 8 May 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (9) , 2650
Abstract
Although lowering low-density lipoprotein cholesterol (LDL-C) levels following acute myocardial infarction (MI) is the cornerstone of secondary prevention, the attainment of recommended LDL-C goals remains suboptimal in real-world practice. We sought to investigate recurrent adverse events in post-MI patients. From the Korea Acute Myocardial Infarction-National Institutes of Health registry, a total of 5049 patients with both measurements of plasma LDL-C levels at index admission and at the one-year follow-up visit were identified. Patients who achieved an LDL-C reduction ≥ 50% from the index MI and an LDL-C level ≤ 70 mg/dL at follow-up were classified as target LDL-C achievers. The primary endpoint was a two-year major adverse cardiac and cerebrovascular event (MACCE), including cardiovascular mortality, recurrent MI, and ischemic stroke. Among the 5049 patients, 1114 (22.1%) patients achieved the target LDL-C level. During a median follow-up of 2.1 years, target LDL-C achievers showed a significantly lower incidence (2.2% vs. 3.5%, log-rank p = 0.022) and a reduced adjusted hazard of MACCE (0.63; p = 0.041). In patients with acute MI, achieving a target LDL-C level was associated with a lower incidence and a reduced hazard of recurrent clinical events. These results highlight the need to improve current practices for managing LDL-C levels in real-world settings.Keywords
Funding Information
- Research of Korea Centers for Disease Control and Prevention (2016-ER6304-02)
This publication has 21 references indexed in Scilit:
- Introduction to the Analysis of Survival Data in the Presence of Competing RisksCirculation, 2016
- Multicenter Cohort Study of Acute Myocardial Infarction in Korea – Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry –Circulation Journal, 2016
- Assessing the Validity of Friedewald’s Formula and Anandraja’s Formula For Serum L DL -Cholesterol CalculationJournal of Clinical and Diagnostic Research, 2015
- Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥50% reduction from baseline versus <70mg/dLInternational Journal of Cardiology, 2015
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trialsThe Lancet, 2015
- Consideration of a New Definition of Clinically Relevant Myocardial Infarction After Coronary RevascularizationJACC, 2013
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary SyndromesJAMA, 2004
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Gaining more flexibility in Cox proportional hazards regression models with cubic spline functionsComputer Methods and Programs in Biomedicine, 1997